According to BELLUS Health's latest financial reports the company has a price-to-book ratio of 5.07.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2022-12-31 | 2.56 | -9.4% |
2021-12-31 | 2.82 | 76.5% |
2020-12-31 | 1.60 | -74.02% |
2019-12-31 | 6.16 | 42.7% |
2018-12-31 | 4.31 | 103.73% |
2017-12-31 | 2.12 | -26.23% |
2016-12-31 | 2.87 | -56.49% |
2015-12-31 | 6.60 | -18.6% |
2014-12-31 | 8.10 | 334.13% |
2013-12-31 | 1.87 | 9.6% |
2012-12-31 | 1.70 | -827.18% |
2011-12-31 | -0.2342 | -61.31% |
2010-12-31 | -0.6053 | -44.39% |
2009-12-31 | -1.09 | 85.97% |
2008-12-31 | -0.5853 | -102.45% |
2007-12-31 | 23.9 | -102.45% |
2006-12-31 | -976 | -6985.95% |
2005-12-31 | 14.2 | -24.82% |
2004-12-31 | 18.9 | 42.05% |
2003-12-31 | 13.3 | 41.82% |
2002-12-31 | 9.36 |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | 2.86 | -43.47% | ๐บ๐ธ USA |